scholarly journals Acute Inhibitory Effects of Antidepressants on Lacrimal Gland Secretion in the Anesthetized Rat

2021 ◽  
Vol 62 (7) ◽  
pp. 8
Author(s):  
Martin Dankis ◽  
Ozgu Aydogdu ◽  
Gunnar Tobin ◽  
Michael Winder
2004 ◽  
Vol 122 (5) ◽  
pp. 791
Author(s):  
Martin S. Cogen

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3245
Author(s):  
Sung-Chul Hong ◽  
Jung-Heun Ha ◽  
Jennifer K. Lee ◽  
Sang Hoon Jung ◽  
Jin-Chul Kim

Dry eye syndrome (DES) is a corneal disease often characterized by an irritating, itching feeling in the eyes and light sensitivity. Inflammation and endoplasmic reticulum (ER) stress may play a crucial role in the pathogenesis of DES, although the underlying mechanism remains elusive. Aster koraiensis has been used traditionally as an edible herb in Korea. It has been reported to have wound-healing and inhibitory effects against insulin resistance and inflammation. Here, we examined the inhibitory effects of inflammation and ER stress by A. koraiensis extract (AKE) in animal model and human retinal pigmented epithelial (ARPE-19) cells. Oral administration of AKE mitigated DE symptoms, including reduced corneal epithelial thickness, increased the gap between lacrimal gland tissues in experimental animals and decreased tear production. It also inhibited inflammatory responses in the corneal epithelium and lacrimal gland. Consequently, the activation of NF-κB was attenuated by the suppression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Moreover, AKE treatment ameliorated TNF-α-inducible ocular inflammation and thapsigargin (Tg)-inducible ER stress in animal model and human retinal pigmented epithelial (ARPE-19) cells. These results prove that AKE prevents detrimental functional and histological remodeling on the ocular surface and in the lacrimal gland through inhibition of inflammation and ER stress, suggesting its potential as functional food material for improvement of DES.


2006 ◽  
Vol 96 (1) ◽  
pp. 126-135 ◽  
Author(s):  
Driss Zoukhri ◽  
Elizabeth Macari ◽  
Sun H. Choi ◽  
Claire L. Kublin

2018 ◽  
Vol 11 (4) ◽  
pp. 1138-1148 ◽  
Author(s):  
Sumit Bhattacharya ◽  
Laura García-Posadas ◽  
Robin R. Hodges ◽  
Helen P. Makarenkova ◽  
Sharmila Masli ◽  
...  

1988 ◽  
Vol 254 (3) ◽  
pp. G300-G306
Author(s):  
D. A. Dartt ◽  
M. Shulman ◽  
K. L. Gray ◽  
S. R. Rossi ◽  
C. Matkin ◽  
...  

To determine whether biologically active peptides can stimulate lacrimal gland secretion, we measured fluid and protein secretion from the cannulated lacrimal gland excretory duct of anesthetized rabbits after arterial injection of various peptides. Vasoactive intestinal peptide (VIP, 0.003-3 nmol) and porcine histidine isoleucine-containing peptide (PHI, 0.01-3 nmol) stimulated fluid and protein secretion in a dose-dependent manner. Cholecystokinin octapeptide (CCK-8, 0.01-3 nmol) stimulated fluid but not protein secretion. Neither bombesin nor eledoisin in doses as high as 3 nmol stimulated fluid or protein secretion. When combinations of high or low doses of VIP and the cholinergic agonist acetylcholine (ACh) were injected simultaneously, fluid and protein secretion was additive. We concluded that VIP and PHI stimulated secretion of lacrimal gland fluid and protein, CCK-8 stimulated secretion of fluid, and bombesin and eledoisin did not stimulate either fluid or protein secretion. VIP and ACh, both found in lacrimal gland nerve endings, stimulate lacrimal gland fluid and protein secretion by separate pathways.


2005 ◽  
Vol 3 ◽  
pp. S69
Author(s):  
Claire L. Kublin ◽  
Liz Macari ◽  
Sun H. Choi ◽  
Driss Zoukhri

2015 ◽  
Vol 31 (8) ◽  
pp. 426-431
Author(s):  
Firat Erdogan ◽  
Mustafa Eliaçık ◽  
Evrim Senkal ◽  
Sevil Karaman Erdur ◽  
Kudret Kulak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document